By our calculation, Pfizer's consumer business has an implied market value of US$4.6 billion ($6.9 billion) but could be sold for 2 to 2.5 times that amount, or US$10 billion.
By our calculation, Pfizer's consumer business has an implied market value of $4.6 billion but could be sold for 2 to 2.5 times that amount, or $10 billion.